Past Researches

• A study to evaluate the efficacy and safety of xxx in patients with Chronic Stable Angina Pectoris. 
• A study to assess the long-term safety and efficacy of xxx. 

Objective of the Study:

• Long-term Safety Assessment: The primary goal is to evaluate the safety of the intervention ("xxx") over an extended period.
• Long-term Efficacy Assessment: The study aims to assess how effective "xxx" remains over the course of the long-term.

Population Under Investigation:

• Patients with Chronic Stable Angina Pectoris: This study focuses on individuals who have been diagnosed with Chronic Stable Angina Pectoris, a condition characterized by chest pain or discomfort due to reduced blood flow to the heart muscle.

Nature of the Intervention ("xxx"):

• The specific details about "xxx" are not provided, but it is the intervention being studied for its long-term safety and efficacy in individuals with Chronic Stable Angina Pectoris.

•  A study to evaluate the effectiveness and safety of xxx in patients with moderate to severe chronic low back pain.

• Efficacy Assessment: The study focuses on determining how effective the "xxx" treatment or medication is.
• Safety Assessment: In addition to efficacy, the safety of the treatment will be analyzed to ensure that it does not cause significant adverse effects.

Target Population:

• Patients with Chronic Low Back Pain: The study will be conducted in patients experiencing continuous pain in the lower back, classified as moderate to severe intensity.

Type of Pain:

• Chronic: Indicates that the pain persists for an extended period rather than being acute or short-term.

Medication or Treatment ("xxx"):

• The specific name of the medication or treatment is not provided, but it refers to an intervention being evaluated in the context of chronic low back pain.

Pain Severity:

• Moderate to Severe: Study participants will experience pain levels ranging from moderate to severe.

• A phase III study to investigate the efficacy and safety of xxx in addition to standard of care, on the progression of kidney disease in subjects with Type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease. 
• A study to investigate the efficacy and safety of xxx as adjunct therapy to insulin in the treatment of type 1 diabetes.                                                                                                                
• A comparison of xxx versus xxx as Basal Insulin Treatment in combination with oral anti-hyperglycemia medications in insulin naïve patients with Type 2 diabetes mellitus. 
• A study to investigate the effect of xxx on Blood Pressure and heart rate as assessed by ambulatory blood pressure monitoring, in patients with Type 2 diabetes.                
• A study comparing the efficacy of xxx in a population of insulin naïve subjects with type 2 diabetes mellitus currently treated with xxx, qualifying for intensified treatment.       

• A study of objective endpoints in subjects with acute bacterial skin and skin structure infections treated with xxx.  
• An observational prospective registry of the efficacy and safety and adherence to therapy of xxx in patients chronically infected with hepatitis C virus.        
• A study to evaluate the efficacy and safety of oral xxx versus oral xxx in the treatment of complicated skin and skin structure infections (cSSSI). 
• A study to evaluate the immunogenicity, reactogenicity and safety of xxx, xxx and xxx when co-administered with two doses of xxx as compared to in healthy infants 6-12 weeks of age.        

• Evaluation of medical food for chronic ulcers. 

Study Objective:

• The primary goal is likely to assess the effectiveness and safety of a particular intervention in treating or managing Diabetic Foot Ulcers.

Patient Population:

• Participants in the study are likely to be individuals diagnosed with diabetes who are experiencing foot ulcers. Diabetes is a common condition associated with various complications, and foot ulcers are a significant concern due to impaired wound healing in diabetic patients.

•  A study to assess the effect of xxx versus xxx and xxx on arterial blood pressure in Osteoarthrithis patients with controlled essential Hypertension.  

Arterial Blood Pressure as the Primary Outcome:

• The main focus of the study is to measure the impact of the interventions on arterial blood pressure. This may include assessing changes in systolic and diastolic blood pressure over a specified period.

Controlled Essential Hypertension:

• The inclusion of patients with controlled essential hypertension suggests that the study is targeting individuals whose hypertension is already being managed, possibly to assess additional benefits or potential side effects in the context of osteoarthritis.

•  A study to evaluate the efficacy and safety of xxx in patients with Opiod-induced bowel Dysfunction. Phase III.  

•  A study to evaluate the safety and efficacy of intravenous xxx in monospecific antivenom in the treatment of carpet viper envenomation.